The forecasted data indicates a gradual year-on-year increase in liver malignant neoplasms mortality among men in the US, showing a consistent rise from 12.1 deaths per 100,000 men in 2024 to 13.0 deaths in 2028. This represents an approximate annual compound growth rate (CAGR) of around 1.8% over the forecasted period. The stable upward trend suggests ongoing health challenges related to liver cancer among men.
Future trends to watch for include:
- The impact of advancements in liver cancer treatment and their potential to alter mortality rates.
- Lifestyle and environmental factors contributing to the incidence of liver cancer.
- Public health initiatives aimed at early detection and prevention.
